Customer Success Manager

Flatiron Health and Massive Bio Partner to Improve Clinical Trial Enrollment. by Fred Pennic 04/07/2025 Leave a Comment. What You Should Know: – Flatiron Health, a healthtech company focused on transforming clinical research through technology that integrates research into everyday care, has announced a strategic partnership with Massive Bio, a global leader in using artificial intelligence to streamline patient identification and recruitment for clinical trials.– The partnership aims to expand patient identification capabilities and improve clinical trial enrollment across the U.S. Enhance Patient Identification Capabilities and ServicesThis collaboration will utilize Massive Bio’s U.S.-based database to identify patients who may be eligible for clinical trials but are not currently enrolled and are located near participating trial sites. These patients will then be referred to Flatiron’s research sites, where they can be onboarded as new patients and evaluated for potential trial enrollment using Flatiron’s technology and centralized patient identification services.“At Massive Bio, our mission is to make access to clinical trials truly patient-centric, ensuring the right patient is matched to the right trial at the right time—no matter where they live,” said Dr. Arturo Loaiza-Bonilla, Co-Founder and Chief Medical Officer at Massive Bio. “By pairing our AI-driven platform and concierge services with Flatiron Health’s extensive research infrastructure, we can help physicians and care teams expedite trial enrollment, reduce disparities in access, and improve outcomes for more patients.”

What You Should Know: – Flatiron Health, a healthtech company focused on revolutionizing clinical research through technology integration, has announced a collaboration with NRG Oncology, a clinical research consortium within the National Cancer Institute’s (NCI) National Clinical Trials Network (NCTN). – The partnership aims to deploy Flatiron’s Clinical Pipe™ in a multicenter NRG clinical trial, streamlining data entry and accelerating study timelines.Supporting NCI-Sponsored Trials w/ NRG OncologyFlatiron Clinical Pipe™, a cutting-edge electronic health record (EHR) to electronic data capture (EDC) connector, is designed to significantly improve the efficiency and reduce the time and effort required for clinical study data entry. By automating the transfer of data from EHRs to EDC systems, the technology minimizes manual data entry, a known burden for clinical trial site teams.This collaboration marks a significant expansion of Flatiron Clinical Pipe™ use cases, now extending to NCTN-sponsored studies. By leveraging Flatiron’s EHR-to-EDC technology, NRG Oncology seeks to alleviate the administrative burden on its network of over 1,300 research sites worldwide, streamline data management, and accelerate the pace of clinical trials.In conjunction with the trial deployment, NRG and Flatiron will conduct a correlative study to rigorously assess the efficiency of Flatiron Clinical Pipe™ compared to traditional data entry methods. This study will provide valuable insights into the real-world impact of the technology on clinical trial workflows.Flatiron Clinical Pipe Research/OutcomesPrevious research published in the journal ESMO Real World Data and Digital Oncology has demonstrated the significant time-saving potential of Flatiron Clinical Pipe™. The study revealed that teams using the technology were able to accurately transfer thousands of data points, representing the completion of hundreds of case report forms (CRFs), with an average completion time of just 37 seconds per CRF. This represents a substantial reduction in data entry time over the course of a clinical trial.“We are very excited about the rich potential of this collaboration with our partners at Flatiron, a leader in healthcare systems technology

Reduce Clinical Trial Burden with Flatiron Clinical Pipe™: EHR-to-EDC Integration. by Fred Pennic 03/05/2025 Leave a Comment. What You Should Know: – Flatiron Health, a healthcare technology company, today announced a collaboration with the University of Colorado Comprehensive Cancer Center (CU Cancer Center) and UCHealth to implement Flatiron Clinical Pipe™, an innovative solution that streamlines data capture for clinical trials. – The partnership aims to accelerate cancer research and improve patient care by reducing administrative burden and enhancing the efficiency of clinical studies.Flatiron Clinical Pipe™Flatiron Clinical Pipe™ is an electronic health record (EHR) to electronic data capture (EDC) connector that automates the transfer of clinical trial data from the EHR to the EDC system. This eliminates the need for manual data entry, which is often time-consuming and prone to errors.Key features and benefits of Flatiron Clinical Pipe include: Reduced administrative burden: Eliminates manual data entry, freeing up research staff to focus on other critical tasks.Improved accuracy: Reduces errors associated with manual data entry, ensuring data integrity and reliability.Enhanced efficiency: Accelerates the clinical trial process by streamlining data capture and analysis.Increased capacity: Enables research sites to conduct more clinical trials and enroll more patients.Improved patient care: Allows clinicians to spend more time with patients and less time on administrative tasks.Real-World ImpactResearch published in ESMO Real-World Data and Digital Oncology demonstrates the significant impact of Flatiron Clinical Pipe. Users were able to transfer data in an average of 37 seconds, significantly faster than manual entry methods. The platform enabled the efficient transfer of thousands of data points, streamlining the clinical trial process.“Collaborating with the CU Cancer Center and UCHealth, market-leading and innovative cancer care providers, is an incredible opportunity to advance our shared vision to reimagine how clinical trials are executed,” said Emily Akin, Head of Research Network at Flatiron Health